TARGET N V BIOTECH Insider Trading $ESPR Esperion Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for TARGET N V BIOTECH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TARGET N V BIOTECH. TARGET N V BIOTECH is 10% Owner in Monogram Biosciences, Inc. ($VLGC) and 10% Owner in Molecular Templates, Inc. ($MTEM) and 10% Owner in MACROGENICS INC ($MGNX) and 10% Owner in Radius Health, Inc. ($RDUS) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and 10% Owner in Cidara Therapeutics, Inc. ($CDTX).
TARGET N V BIOTECH in Esperion Therapeutics, Inc.
Trading Symbol: ESPRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TARGET N V BIOTECH: 10% Owner
Holdings: 4,097,964 shares
Current Value: $72,370,044
Latest Transaction: May 07 2021
$ESPR Market Capitalization: $454.22M
$ESPR Previous Close: $17.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of TARGET N V BIOTECH in Esperion Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CDTX, ESPR, MGNX, MTEM, VLGC, RDUS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2021 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 20.57 | 80,000 | 1,645,632 | 4,177,964 | 4.1 M to 4.2 M (+1.95 %) |
May 07 2021 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 20.02 | 150,000 | 3,002,850 | 4,097,964 | 3.9 M to 4.1 M (+3.80 %) |
Nov 04 2020 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 25.31 | 200,000 | 5,062,120 | 3,947,964 | 3.7 M to 3.9 M (+5.34 %) |
Jan 27 2020 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 52.12 | 20,000 | 1,042,398 | 3,747,964 | 3.7 M to 3.7 M (+0.54 %) |
Nov 08 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 37.30 | 75,000 | 2,797,560 | 3,727,964 | 3.7 M to 3.7 M (+2.05 %) |
Sep 06 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 33.78 | 80,000 | 2,702,208 | 3,652,964 | 3.6 M to 3.7 M (+2.24 %) |
Jul 25 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 42.65 | 50,000 | 2,132,565 | 3,572,964 | 3.5 M to 3.6 M (+1.42 %) |
Mar 15 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 49.89 | 50,000 | 2,494,355 | 3,522,964 | 3.5 M to 3.5 M (+1.44 %) |
Jan 07 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 41.29 | 80,000 | 3,303,256 | 3,472,964 | 3.4 M to 3.5 M (+2.36 %) |
Dec 26 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 39.91 | 50,000 | 1,995,725 | 3,392,964 | 3.3 M to 3.4 M (+1.50 %) |
Dec 19 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 47.73 | 60,000 | 2,864,070 | 3,342,964 | 3.3 M to 3.3 M (+1.83 %) |
Aug 06 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 46.14 | 50,000 | 2,306,970 | 3,282,964 | 3.2 M to 3.3 M (+1.55 %) |
Jul 13 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 41.77 | 50,000 | 2,088,300 | 3,232,964 | 3.2 M to 3.2 M (+1.57 %) |
Jul 03 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 39.48 | 50,000 | 1,973,805 | 3,182,964 | 3.1 M to 3.2 M (+1.60 %) |
Jun 25 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 38.57 | 60,000 | 2,314,224 | 3,132,964 | 3.1 M to 3.1 M (+1.95 %) |
Jun 11 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 37.79 | 60,000 | 2,267,292 | 3,072,964 | 3 M to 3.1 M (+1.99 %) |
Jun 07 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 38.47 | 60,000 | 2,308,440 | 3,012,964 | 3 M to 3 M (+2.03 %) |
May 22 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 38.77 | 80,000 | 3,101,760 | 2,952,964 | 2.9 M to 3 M (+2.78 %) |
May 22 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 42.24 | 50,000 | 2,112,010 | 2,872,964 | 2.8 M to 2.9 M (+1.77 %) |
Page: 1